Stay updated with breaking news from Mark Swallow. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Memory CD8+ T cell response found as early as two weeks after the first administration of EO2401, expanding to up to 5% of circulating specific CD8+ T cells in some patients Immunological
/PRNewswire/ -- Enterome, a clinical stage biopharmaceutical company developing first-in-class immunomodulatory drugs based on its bacterial Mimicry drug...
/PRNewswire/ -- Enterome, a clinical stage biopharmaceutical company developing first-in-class immunomodulatory drugs based on its bacterial Mimicry drug...
/PRNewswire/ -- Enara Bio, a biotechnology company advancing novel T cell directed immunotherapies against unconventional, shared, cancer-specific antigens,...
OSLO, Norway, Nov. 3, 2022 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANOV) ("Nordic Nanovector" or the "Company") announces the progress it has made in designing and developing a portfolio